Cargando…

Hepcidin and Iron in Health and Disease

Hepcidin, the iron-regulatory hormone, determines plasma iron concentrations and total body iron content. Hepcidin, secreted by hepatocytes, functions by controlling the activity of the cellular iron exporter ferroportin, which delivers iron to plasma from intestinal iron absorption and from iron st...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemeth, Elizabeta, Ganz, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943683/
https://www.ncbi.nlm.nih.gov/pubmed/35905974
http://dx.doi.org/10.1146/annurev-med-043021-032816
_version_ 1784891761467850752
author Nemeth, Elizabeta
Ganz, Tomas
author_facet Nemeth, Elizabeta
Ganz, Tomas
author_sort Nemeth, Elizabeta
collection PubMed
description Hepcidin, the iron-regulatory hormone, determines plasma iron concentrations and total body iron content. Hepcidin, secreted by hepatocytes, functions by controlling the activity of the cellular iron exporter ferroportin, which delivers iron to plasma from intestinal iron absorption and from iron stores. Hepcidin concentration in plasma is increased by iron loading and inflammation and is suppressed by erythropoietic stimulation and during pregnancy. Hepcidin deficiency causes iron overload in hemochromatosis and anemias with ineffective erythropoiesis. Hepcidin excess causes iron-restrictive anemias including anemia of inflammation. The development of hepcidin diagnostics and therapeutic agonists and antagonists should improve the treatment of iron disorders.
format Online
Article
Text
id pubmed-9943683
institution National Center for Biotechnology Information
language English
publishDate 2023
record_format MEDLINE/PubMed
spelling pubmed-99436832023-02-21 Hepcidin and Iron in Health and Disease Nemeth, Elizabeta Ganz, Tomas Annu Rev Med Article Hepcidin, the iron-regulatory hormone, determines plasma iron concentrations and total body iron content. Hepcidin, secreted by hepatocytes, functions by controlling the activity of the cellular iron exporter ferroportin, which delivers iron to plasma from intestinal iron absorption and from iron stores. Hepcidin concentration in plasma is increased by iron loading and inflammation and is suppressed by erythropoietic stimulation and during pregnancy. Hepcidin deficiency causes iron overload in hemochromatosis and anemias with ineffective erythropoiesis. Hepcidin excess causes iron-restrictive anemias including anemia of inflammation. The development of hepcidin diagnostics and therapeutic agonists and antagonists should improve the treatment of iron disorders. 2023-01-27 2022-07-29 /pmc/articles/PMC9943683/ /pubmed/35905974 http://dx.doi.org/10.1146/annurev-med-043021-032816 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See credit lines of images or other third-party material in this article for license information.
spellingShingle Article
Nemeth, Elizabeta
Ganz, Tomas
Hepcidin and Iron in Health and Disease
title Hepcidin and Iron in Health and Disease
title_full Hepcidin and Iron in Health and Disease
title_fullStr Hepcidin and Iron in Health and Disease
title_full_unstemmed Hepcidin and Iron in Health and Disease
title_short Hepcidin and Iron in Health and Disease
title_sort hepcidin and iron in health and disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943683/
https://www.ncbi.nlm.nih.gov/pubmed/35905974
http://dx.doi.org/10.1146/annurev-med-043021-032816
work_keys_str_mv AT nemethelizabeta hepcidinandironinhealthanddisease
AT ganztomas hepcidinandironinhealthanddisease